scispace - formally typeset
D

David W. Johnson

Researcher at University of Queensland

Publications -  2880
Citations -  157072

David W. Johnson is an academic researcher from University of Queensland. The author has contributed to research in topics: Peritoneal dialysis & Kidney disease. The author has an hindex of 160, co-authored 2714 publications receiving 140778 citations. Previous affiliations of David W. Johnson include Minnesota Department of Transportation & Open University.

Papers
More filters
Journal ArticleDOI

Computed tomographic observations on subcutaneous fat: implications for liposuction.

TL;DR: It is shown that the superficial fascia, which separates the superficial and deep layers of subcutaneous fat, forms a continuous circumferential fascial plane around the external oblique muscle.
Journal ArticleDOI

Effects of cooperative and individualistic instruction on the achievement of handicapped, regular, and gifted students

TL;DR: The results indicate that cooperative learning experiences promoted higher achievement, greater retention, more positive attitudes among students, and higher self-esteem than did individualistic learning experiences.
Journal ArticleDOI

Kidney transplant outcomes are related to tacrolimus, mycophenolic acid and prednisolone exposure in the first week.

TL;DR: A potential role for individualized initial dosing or early therapeutic monitoring of all three immunosuppressant medications is suggested and the importance of achieving early target exposure is highlighted.
Journal ArticleDOI

A modified Girard derivatizing reagent for universal profiling and trace analysis of aldehydes and ketones by electrospray ionization tandem mass spectrometry

TL;DR: HTMOB is a modified Girard derivatizing reagent synthesized to improve the sensitivity of analysis of aldehydes and ketones with electrospray ionization tandem mass spectrometry and applications described include the profiling of ketones, ketoacids and ketodiacids in the urine of children with ketosis and the profiles of long-chain aldeHydes incorporated in plasma plasmalogens.
Journal ArticleDOI

End-stage kidney disease due to scleroderma—outcomes in 127 consecutive ANZDATA registry cases

TL;DR: Scleroderma was found to be an independent predictor for mortality, median survival, renal recovery and renal recovery, and five year deceased donor and live donor renal allograft survival rates of recipients with scleroderMA were 53 and 100%, respectively.